Trial of SYNC-T SV-101 Immunotherapy for Patients With Advanced / Metastatic Solid Tumors
RECRUITING
TRIAL INFORMATIONELIGIBILITYLOCATIONSNEXT STEPSRESOURCES
Trial Purpose
This is a non-randomized, open-label trial. The purpose of this study is to assess the efficacy and safety of SYNC-T™ SV-101 in patients with advanced / metastatic solid tumor cancers such as lymphomas, melanomas, carcinomas, breast, lung, prostate, colorectal, bladder, kidney, pancreas, ovarian, thyroid, and uterine. This trial is free to participate in and each patient will receive the same SYNC-T™ SV-101 regimen.
VIEW FULL TRIAL INFORMATION ON CLINICALTRIALS.GOV
NATIONAL TRIAL REFERENCE NUMBER
When you contact Williams Cancer Institute, please have the trial identifier number available.
Current Trial Phase
Trial Start and End Dates
Phase 1
A phase I clinical trial can test the safety, side effects, and efficacy of a new treatment. It may also test the best way to give a new treatment and how the treatment affects the body. Phase I clinical trials usually include only a small number of patients who have not been helped by other treatments. Placebos (inactive treatments) are not used in phase 1 trials.
Trial start date
Estimated trial completion date
February 16, 2023
December 31, 2023
Conditions
Advanced / metastatic solid tumor cancers
Age Range
18+
Sex
All
Trial Locations
Locations may have changed or been added. Please contact the Williams Cancer Institute to confirm the nearest trial site.
HOSPITAL DIOMED
Av. Observatorio 354,
Colonia 16 de Septiembre,
Alcaldía de Miguel Hidalgo, CDMX, 11810
Phone: +52 5510682910
Facebook
Twitter
Youtube
Instagram
Linkedin
ABOUT HOSPITAL DIOMED
Inaugurated in 2004, the DioMed Hospital offers an innovative proposal in health services in Mexico, forming a Center for Clinical and Surgical Medical Specialties of High Level, whose main objective is to guarantee the best care for the well-being and health of its users, so the philosophy of service lies in providing the best treatment with fair and accessible rates. The DioMed Hospital responds to a new health philosophy that proposes access to the best specialized and high-quality comprehensive medical care, with true human sense.
HOSPITAL DIOMED
Av. Observatorio 354,
Colonia 16 de Septiembre,
Alcaldía de Miguel Hidalgo, CDMX, 11810
Phone: +52 5510682910
Facebook
Twitter
Youtube
Instagram
Linkedin
ABOUT HOSPITAL DIOMED
Inaugurated in 2004, the DioMed Hospital offers an innovative proposal in health services in Mexico, forming a Center for Clinical and Surgical Medical Specialties of High Level, whose main objective is to guarantee the best care for the well-being and health of its users, so the philosophy of service lies in providing the best treatment with fair and accessible rates. The DioMed Hospital responds to a new health philosophy that proposes access to the best specialized and high-quality comprehensive medical care, with true human sense.
WHAT CAN YOU DO NEXT?
If you think this clinical trial might be a good fit and you are interested in taking part, please contact the Williams Cancer Institute to take the next step. You can also fill out our candidacy assessment form.
Contact Williams Cancer Institute
USA
Toll-free: +1-888-312-6073
Email: support@sync-t-trials.com
ESPAÑOL
Número de teléfono: +52 5511638692
Mensaje electrónico: info@sync-t-trials.mx
NATIONAL TRIAL REFERENCE NUMBER
When you contact Williams Cancer Institute, please have the trial identifier number available.
CONTACT US
Immunotherapy Resources
TRIAL INFORMATION
Trial Purpose
This is a non-randomized, open-label trial. The purpose of this study is to assess the efficacy and safety of SYNC-T™ SV-101 in patients with advanced / metastatic solid tumor cancers. Each patient will receive the same SYNC-T™ SV-101 regimen.
VIEW FULL TRIAL INFORMATION ON CLINICALTRIALS.GOV
NATIONAL TRIAL REFERENCE NUMBER
When you contact Williams Cancer Institute, please have the trial identifier number available.
Current Trial Phase
Phase 1
A phase I clinical trial can test the safety, side effects, and efficacy of a new treatment. It may also test the best way to give a new treatment and how the treatment affects the body. Phase I clinical trials usually include only a small number of patients who have not been helped by other treatments. Placebos (inactive treatments) are not used in phase 1 trials.
Trial Start and End Dates
Trial start date
February 16, 2023
Estimated trial completion date
December 31, 2023
ELIGIBILITY
Conditions
Advanced / metastatic solid tumors
Age Range
18+
Sex
All
LOCATIONS
HOSPITAL DIOMED
Av. Observatorio 354,
Colonia 16 de Septiembre,
Alcaldía de Miguel Hidalgo, CDMX, 11810
Phone: +52 5510682910
Facebook
Twitter
Youtube
Instagram
Linkedin
ABOUT HOSPITAL DIOMED
Inaugurated in 2004, the DioMed Hospital offers an innovative proposal in health services in Mexico, forming a Center for Clinical and Surgical Medical Specialties of High Level, whose main objective is to guarantee the best care for the well-being and health of its users, so the philosophy of service lies in providing the best treatment with fair and accessible rates. The DioMed Hospital responds to a new health philosophy that proposes access to the best specialized and high-quality comprehensive medical care, with true human sense.
NEXT STEPS
WHAT CAN YOU DO NEXT?
If you think this clinical trial might be a good fit and you are interested in taking part, please contact the Williams Cancer Institute to take the next step. You can also fill out our candidacy assessment form to the right.
Contact Williams Cancer Institute
USA
Toll-free: +1-888-312-6073
Email: support@sync-t-trials.com
ESPAÑOL
Número de teléfono: +52 5511638692
Mensaje electrónico: info@sync-t-trials.mx
NATIONAL TRIAL REFERENCE NUMBER
When you contact Williams Cancer Institute, please have the trial identifier number available.